Mumbai, Oct. 14 -- Godavari Biorefineries announced that its United States-based patent application, entitled "5-HYDROXY-1,4 NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER" has been granted.

This patent protects a novel class of compounds that effectively inhibit cancer and cancer stem cells, showing significant potential against various cancer types, including breast and prostate.

Published by HT Digital Content Services with permission from Capital Market....